Skip to main content
B

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 1,648 across all filing types
Latest filing 2025-10-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于召开2025年第二次临时股东会的通知
Regulatory Filings
2025-10-23 Chinese
公司章程(2025年10月)
Regulatory Filings
2025-10-23 Chinese
公司章程修订对照表(2025年10月)
Regulatory Filings
2025-10-23 Chinese
董事会提名委员会工作细则(2025年10月)
Regulatory Filings
2025-10-23 Chinese
控股子公司管理制度(2025年10月)
Regulatory Filings
2025-10-23 Chinese
证券投资、期货和衍生品交易管理制度(2025年10月)
Regulatory Filings
2025-10-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.